US Capitol Capsule: Biopharma among targets for trade secret theft, USTR says
This article was originally published in Scrip
Executive Summary
The theft of US biopharmaceutical and other sector trade secrets, along with other forms of economic espionage, is on the rise, resulting in significant costs to American companies, ultimately threatening the nation's economic security, the United States Trade Representative (USTR) said last week.